Is UBIO or JNJ a better dividend investment in 2026?

UBIO currently yields 11.26% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: UBIO offers higher current income.

What is the dividend yield difference between UBIO and JNJ?

UBIO has a forward dividend yield of 11.26% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 7.90 percentage points.

Home › Compare › UBIO vs JNJ

UBIO vs JNJ: Dividend Comparison 2026

UBIO yields 11.26% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 UBIO wins by $22.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

UBIO

● Live price

11.26%

Share price

$17.77

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$42.1K

Annual income

$2,276.96

Full UBIO calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — UBIO vs JNJ

📍 UBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	UBIO	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, UBIO + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

UBIO pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBIO

Annual income on $10K today (after 15% tax)

$956.93/yr

After 10yr DRIP, annual income (after tax)

$1,935.42/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, UBIO beats the other by $1,231.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBIO + JNJ for your $10,000?

UBIO: 50%JNJ: 50%

100% JNJ50/50100% UBIO

Portfolio after 10yr

$31.0K

Annual income

$1,552.37/yr

Blended yield

5.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

UBIO

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBIO buys

JNJ buys

No recent congressional trades found for UBIO or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricUBIOJNJ

Forward yield	11.26% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$42.1K ✓	$20.0K
Annual income after 10y	$2,276.96 ✓	$827.78
Total dividends collected	$16.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: UBIO vs JNJ ($10,000, DRIP)

Year	UBIO Portfolio	UBIO Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,826	$1,125.80	$10,676	$355.77	+$1.1K → UBIO
2	$13,898	$1,244.25	$11,407	$389.39	+$2.5K → UBIO
3	$16,237	$1,366.60	$12,198	$426.53	+$4.0K → UBIO
4	$18,866	$1,492.18	$13,056	$467.62	+$5.8K → UBIO
5	$21,807	$1,620.34	$13,987	$513.12	+$7.8K → UBIO
6	$25,084	$1,750.40	$14,998	$563.56	+$10.1K → UBIO
7	$28,722	$1,881.71	$16,098	$619.52	+$12.6K → UBIO
8	$32,746	$2,013.64	$17,295	$681.69	+$15.5K → UBIO
9	$37,183	$2,145.58	$18,599	$750.82	+$18.6K → UBIO
10	$42,063	$2,276.96	$20,022	$827.78	+$22.0K → UBIO

UBIO vs JNJ: Complete Analysis 2026

UBIO — Stock

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index (the index). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Full UBIO Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this UBIO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBIO vs SCHD UBIO vs JEPI UBIO vs O UBIO vs KO UBIO vs MAIN UBIO vs ABBV UBIO vs MRK UBIO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.